Skip to content
Home/Companies/MedTech/Arcoma

Arcoma

MedTech·Sweden·Exited 2014·Held 4yr
Entry
2010
Hold
4yr
Exit
2014

Who owns Arcoma?

Arcoma was owned by Sunstone Life Science Ventures through Sunstone Life Science Ventures III (2007 vintage) from 2010 to 2014, exited via IPO.

Hand-verified · updated 2026-08-18

Sunstone Life Science Ventures
Investor
Sunstone Life Science Ventures
Sunstone Life Science Ventures III · 2007 · VC

Key facts

HQSweden
SectorMedTech
StatusAcquired
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2014

More from Sunstone Life Science Ventures III

Other portfolio companies in the same fund.

MinervaX
MinervaX
Active
BiotechDenmark· 2014
Cantargia
Exited 2015
BiotechSweden· 2013
Opsona Therapeutics
Exited 2019
BiotechIreland· 2013
Follicum
Exited 2014
BiotechSweden· 2012
to
Galecto
Exited 2020
BiotechDenmark· 2012
Orphazyme
Orphazyme
Exited 2017
BiotechDenmark· 2011

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Biocomposites
Biocomposites
Active
TA AssociatesUS
CMR Surgical
CMR Surgical
Active
LightrockUK
Neuromod Devices
Neuromod Devices
Active
Enterprise IrelandIreland
Optos
Exited 2015
Amadeus Capital PartnersUK
to
Ardos
Active
Delphinus Venture CapitalDenmark· 2026
Axomove
Axomove
Active
Go CapitalFrance· 2026
Track Arcoma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Arcoma?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Arcoma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue